{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:46:47Z","timestamp":1793731607285,"version":"4.6.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1A6A1A03033084"],"award-info":[{"award-number":["2019R1A6A1A03033084"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jconrel.2023.04.015","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T01:38:09Z","timestamp":1681349889000},"page":"404-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Novel pro-and eukaryotic expression plasmid expressing omicron antigens delivered via Salmonella elicited MHC class I and II based protective immunity"],"prefix":"10.1016","volume":"357","author":[{"given":"Chandran","family":"Sivasankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamith","family":"Hewawaduge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.04.015_bb0005","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0015","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41598-022-09783-9","article-title":"The determinants of COVID-19 morbidity and mortality across countries","volume":"12","author":"Chang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0020","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","article-title":"SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse","volume":"6","author":"Konings","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0035","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.11604\/pamj.2022.41.84.33373","article-title":"Omicron: the highly mutational COVID-19 variant with immune escape","volume":"41","author":"Khajotia","year":"2022","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103997","article-title":"Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern","volume":"79","author":"Mohandas","year":"2022","journal-title":"EBioMedicine."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0050","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMc2210648","article-title":"Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination","volume":"387","author":"Shen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41421-022-00472-5","article-title":"Neutralization of Omicron BA.4\/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0060","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S1473-3099(22)00663-6","article-title":"Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies","volume":"22","author":"Sheward","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0070","first-page":"1","article-title":"Omicron BA.4\/BA.5 escape neutralizing immunity elicited by BA.1 infection","volume":"13","author":"Khan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105273","article-title":"Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection","volume":"156","author":"Cheng","year":"2022","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0080","article-title":"Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies","author":"Planas","year":"2022","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0085","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster","author":"Kurhade","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0090","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S1473-3099(22)00692-2","article-title":"BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5","volume":"22","author":"Tartof","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2021.1042","article-title":"Helping the public understand adverse events associated with COVID-19 Vaccinations: lessons learned from functional neurological disorder","volume":"78","author":"Kim","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0105","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.121.055891","article-title":"Myocarditis temporally associated with COVID-19 vaccination","volume":"144","author":"Rosner","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2023.04.015_bb0115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.121.055913","article-title":"Myocarditis after BNT162b2 and mRNA-1273 vaccination","volume":"144","author":"Larson","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2021.07.005","article-title":"An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury","volume":"75","author":"Lodato","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s40618-022-01863-x","article-title":"SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature","volume":"45","author":"Ruggeri","year":"2022","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0135","series-title":"COVID-19 Vaccine Development: Milestones, Lessons and Prospects","author":"Li","year":"2022"},{"key":"10.1016\/j.jconrel.2023.04.015_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15173","article-title":"Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination","volume":"34","author":"Myrdal","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jdin.2022.01.011","article-title":"Cutaneous reactions to COVID-19 vaccines: a review","volume":"7","author":"Tan","year":"2022","journal-title":"JAAD Int."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0091-6749(99)70489-6","article-title":"Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity","volume":"103","author":"Kalish","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ced.14856","article-title":"Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study","volume":"47","author":"Papadimitriou","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-022-01096-z","article-title":"Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems","volume":"53","author":"Aganja","year":"2022","journal-title":"Vet. Res."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jare.2021.07.007","article-title":"Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection","volume":"36","author":"Jawalagatti","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0180","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.ymthe.2022.01.042","article-title":"Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2","volume":"30","author":"Jawalagatti","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0185","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-020-17972-1","article-title":"A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0190","article-title":"Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"25","author":"Perera","year":"2020","journal-title":"Euro Surveill. Bull. Eur. Sur Les Mal. Transm"},{"key":"10.1016\/j.jconrel.2023.04.015_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0200","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill Bull. Eur. Sur Les Mal. Transm. = Eur. Commun. Dis. Bull."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.110947","article-title":"Copper-impregnated three-layer mask efficiently inactivates SARS-CoV2","volume":"196","author":"Hewawaduge","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100121","article-title":"Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in golden syrian hamsters","volume":"1","author":"Lee","year":"2020","journal-title":"Cell Reports. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0215","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3389\/fmicb.2017.00872","article-title":"An influenza HA and M2e based vaccine delivered by a novel attenuated salmonella mutant protects mice against homologous H1N1 infection","volume":"8","author":"Hajam","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701501","article-title":"SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants","volume":"12","author":"Mart\u00ednez-Flores","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0225","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ijbiomac.2021.08.076","article-title":"SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review","volume":"188","author":"Fathizadeh","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0230","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1038\/s41467-022-32396-9","article-title":"Omicron BA.4\/BA.5 escape neutralizing immunity elicited by BA.1 infection","volume":"13","author":"Khan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41467-020-20247-4","article-title":"Neutralizing antibody titres in SARS-CoV-2 infections","volume":"12","author":"Lau","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0240","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41467-021-21037-2","article-title":"A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0245","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0400576101","article-title":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides","volume":"101","author":"Bosch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050366","article-title":"Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing","volume":"7","author":"Elshabrawy","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007252","article-title":"Vaccine design for CD8 T lymphocyte responses","volume":"1","author":"Koup","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0260","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1021\/acs.jpclett.0c02421","article-title":"Discovery of COVID-19 inhibitors targeting the SARS-CoV-2 Nsp13 helicase","volume":"11","author":"White","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0265","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","article-title":"Nonviral gene delivery: principle, limitations, and recent progress","volume":"11","author":"Al-Dosari","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0270","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0264-410X(91)90129-T","article-title":"Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine","volume":"9","author":"Kantele","year":"1991","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0275","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","article-title":"Review on the recent advances on typhoid vaccine development and challenges ahead","volume":"71","author":"Syed","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0280","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jmv.26320","article-title":"SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen","volume":"93","author":"Wang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040316","article-title":"Immunogenicity and neutralizing activity comparison of SARS-CoV-2 spike full-length and subunit domain proteins in young adult and old-aged mice","volume":"9","author":"Kim","year":"2021","journal-title":"Vaccines."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0290","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0295","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109664","article-title":"Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2","volume":"36","author":"Dangi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0305","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/cib.3.6.13495","article-title":"Multifaceted regulation of T cells by CD44","volume":"3","author":"Baaten","year":"2010","journal-title":"Commun Integr. Biol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0310","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.0802325","article-title":"Role of CD44 in the differentiation of Th1 and Th2 cells: CD44-deficiency enhances the development of Th2 effectors in response to sheep RBC and chicken ovalbumin","volume":"183","author":"Guan","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0315","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1083\/jcb.137.5.1137","article-title":"An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function","volume":"137","author":"Weiss","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0320","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.20041463","article-title":"Interferon-\u03b3 acts directly on CD8+ T cells to increase their abundance during virus infection","volume":"201","author":"Whitmire","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0325","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4049\/jimmunol.180.9.6159","article-title":"A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection","volume":"180","author":"Yang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0330","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.4049\/jimmunol.158.9.4260","article-title":"IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo","volume":"158","author":"Hobart","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.015_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7020037","article-title":"A comparison of plasmid DNA and mRNA as vaccine technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:42:04Z","timestamp":1759164124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923002651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":67,"alternative-id":["S0168365923002651"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.015","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel pro-and eukaryotic expression plasmid expressing omicron antigens delivered via Salmonella elicited MHC class I and II based protective immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}